Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

ANI Pharma Inc (ANIP)

ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,895,259
  • Shares Outstanding, K 22,469
  • Annual Sales, $ 614,380 K
  • Annual Income, $ -18,520 K
  • EBIT $ 163 M
  • EBITDA $ 245 M
  • 60-Month Beta 0.51
  • Price/Sales 2.04
  • Price/Cash Flow 10.04
  • Price/Book 3.39

Options Overview Details

View History
  • Implied Volatility 36.67% (-1.66%)
  • Historical Volatility 40.44%
  • IV Percentile 13%
  • IV Rank 18.51%
  • IV High 73.85% on 07/24/25
  • IV Low 28.23% on 01/17/25
  • Expected Move (DTE 2) 3.19 (3.87%)
  • Put/Call Vol Ratio 0.31
  • Today's Volume 21
  • Volume Avg (30-Day) 247
  • Put/Call OI Ratio 2.50
  • Today's Open Interest 8,115
  • Open Int (30-Day) 5,200
  • Expected Range 79.09 to 85.47

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 1.64
  • Number of Estimates 5
  • High Estimate 1.71
  • Low Estimate 1.56
  • Prior Year 1.35
  • Growth Rate Est. (year over year) +21.48%

Price Performance

See More
Period Period Low Period High Performance
1-Month
75.10 +9.56%
on 01/09/26
87.00 -5.43%
on 01/12/26
+1.89 (+2.35%)
since 12/12/25
3-Month
75.10 +9.56%
on 01/09/26
97.00 -15.18%
on 10/24/25
-6.33 (-7.14%)
since 10/13/25
52-Week
53.35 +54.21%
on 01/14/25
99.50 -17.31%
on 09/10/25
+28.35 (+52.57%)
since 01/13/25

Most Recent Stories

More News
ANI Pharmaceuticals (ANIP) Stock Trades Down, Here Is Why

ANI Pharmaceuticals (ANIP) Stock Trades Down, Here Is Why

ANIP : 82.28 (-2.45%)
Stocks making big moves yesterday: OneMain, Nextpower, ANI Pharmaceuticals, Akamai Technologies, and Lemonade

Stocks making big moves yesterday: OneMain, Nextpower, ANI Pharmaceuticals, Akamai Technologies, and Lemonade

LMND : 81.42 (-5.88%)
AKAM : 88.86 (-2.64%)
OMF : 66.37 (-0.33%)
ANIP : 82.28 (-2.45%)
NXT : 100.24 (+1.17%)
Stocks Recover as Data Storage Companies and Chip Makers Rally

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.17%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.08%. March E-mini S&P...

AMAT : 304.87 (-0.77%)
B : 49.71 (+1.39%)
AVGO : 354.61 (+0.68%)
C : 116.30 (-1.19%)
HL : 24.31 (-0.61%)
HSIC : 75.82 (-0.41%)
CDE : 20.96 (-3.01%)
JPM : 310.90 (-4.19%)
AKAM : 88.86 (-2.64%)
ANIP : 82.28 (-2.45%)
$IUXX : 25,741.95 (-0.18%)
UNH : 333.93 (-1.93%)
Why ANI Pharmaceuticals (ANIP) Stock Is Trading Up Today

Why ANI Pharmaceuticals (ANIP) Stock Is Trading Up Today

ANIP : 82.28 (-2.45%)
Equity Indexes Recover Early Losses as Precious Metals Reach New Record Highs

The S&P 500 Index ($SPX ) (SPY ) today is up +0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.15%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.55%. After opening lower, stock indexes...

B : 49.71 (+1.39%)
C : 116.30 (-1.19%)
HL : 24.31 (-0.61%)
HSIC : 75.82 (-0.41%)
CDE : 20.96 (-3.01%)
JPM : 310.90 (-4.19%)
AKAM : 88.86 (-2.64%)
ANIP : 82.28 (-2.45%)
$IUXX : 25,741.95 (-0.18%)
UNH : 333.93 (-1.93%)
ZNH26 : 112-095 (+0.03%)
MA : 544.99 (-3.76%)
Stocks Retreat on Concerns Over Fed Independence

The S&P 500 Index ($SPX ) (SPY ) today is down -0.23%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.58%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.27%. March E-mini S&P futures...

B : 49.71 (+1.39%)
GTLB : 35.85 (+0.53%)
C : 116.30 (-1.19%)
HL : 24.31 (-0.61%)
HSIC : 75.82 (-0.41%)
CDE : 20.96 (-3.01%)
JPM : 310.90 (-4.19%)
AKAM : 88.86 (-2.64%)
ANIP : 82.28 (-2.45%)
$IUXX : 25,741.95 (-0.18%)
UNH : 333.93 (-1.93%)
ZNH26 : 112-095 (+0.03%)
ANI Pharmaceuticals Highlights Significant Growth in 2025, Provides 2026 Financial Guidance, and Outlines Strategic Priorities

For full year 2025, total net revenues, adjusted non-GAAP EBITDA, and adjusted non-GAAP diluted EPS expected to be within or above guidance ranges of $854 million to $873 million, $221 million to $228...

ANIP : 82.28 (-2.45%)
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 That Underwhelm

1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 That Underwhelm

FRSH : 11.69 (-3.39%)
UNM : 79.33 (-0.91%)
ANIP : 82.28 (-2.45%)
ANI Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

PRINCETON, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present...

ANIP : 82.28 (-2.45%)
3 Reasons to Avoid ANIP and 1 Stock to Buy Instead

3 Reasons to Avoid ANIP and 1 Stock to Buy Instead

ANIP : 82.28 (-2.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The company offers liquid, powder, oral solid dose, cough/cold products, antacids, laxatives, stomach remedies as well as hydrocortisone...

See More

Key Turning Points

3rd Resistance Point 88.60
2nd Resistance Point 86.46
1st Resistance Point 84.37
Last Price 82.28
1st Support Level 80.15
2nd Support Level 78.01
3rd Support Level 75.92

See More

52-Week High 99.50
Last Price 82.28
Fibonacci 61.8% 81.87
Fibonacci 50% 76.43
Fibonacci 38.2% 70.98
52-Week Low 53.35

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar